Single-chain variable fragments (scFvs) selected from a comprehensive RNA library of lymphocytes from breast cancer patients showed excellent selectivity for CD24 and CD44 when combined with epirubicin [22]. This evidence concerns the gene CD24 and breast carcinoma.